Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

NCT02452736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Heart Disease
Cardiovascular Diseases
Arteriosclerosis
Coronary Artery Disease

Interventions

DEVICE: Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System

Sponsor

Medtronic Vascular